That is in contrast with cell and organoid models of AD, where presenilin and APP mutations, like the London and Swedish, as well as Down syndrome chromosome 21 trisomy (3 copies of APP) lead to an increased expression of the Aβ peptide (Choi et al., 2014; Gonzalez et al., 2018). This evidence concerns the gene APP and Alzheimer disease.